"Everybody who knew me were, they were preparing for my passing," Bill Whyte recalls to Newsy. When Whyte got COVID-19, his case was dire. He was on a ventilator for 40 days and received various ...

Researchers at Georgia Health Sciences University have found nitric oxide gas may reduce pain crises of sickle cell disease, according to a GHSU news release. Nitric oxide gas helps “unglue” ...

Are you looking for foods to include in your diet for improved cardiovascular health? Learn about nine foods high in nitric ...

Nitric oxide, a gas that could improve breathing and potentially mitigate severe symptoms of the coronavirus, is among the latest contenders in the race to find a treatment for COVID-19. Naturally ...

HOUSTON — Lung failure is the leading cause of death in patients with COVID-19. That’s why ventilators have become a precious commodity in hospitals across the country. However, a doctor at Methodist ...

Pregnant women with severe and critical COVID-19 had rapid improvement in their heart and lung function along with decreased inflammation when given inhaled nitric oxide gas, a new Massachusetts ...

Mallinckrodt announced that the phase 4 observational registry study evaluating INOmax® (nitric oxide) gas, for inhalation, in preterm neonates with pulmonary hypertension was stopped early due to ...

Inhaling a small dose of nitric oxide gas may one day help sickle cell patients avoid pain crises and live healthier lives, researchers say. Nitric oxide may help normalize a sickle cell patient's ...

Nitric oxide works mechanistically as “a naturally produced molecule that is critical to the immune response against pathogens and infections," according to a press release from Bellerophon ...

STAINES-UPON-THAMES, United Kingdom, May 4, 2020 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced that its observational registry comparing the safety ...

ATLANTA, May 6, 2020 /PRNewswire/ -- GENOSYL DS, an innovative tankless delivery system for inhaled nitric oxide (iNO) was used by Stanford Medicine clinicians via telemedicine for outpatient, at-home ...

- Company ends Phase 4 observational registry early as data achieved statistical significance for non-inferiority in premature neonates compared to term and near-term neonates at planned interim ...